ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 840

Mortality Post Hip Fracture in Rheumatoid Arthritis Compared to General Population Controls, a Population-Based Study

C. Allyson Jones1, Pierre Guy2, Hui Xie3, Eric C. Sayre4 and Diane Lacaille5,6, 1Physical Therapy, University of Alberta, Edmonton, AB, Canada, 2Department of Orthopaedics, University of British Columbia / Centre for Hip Health and Mobility, Vancouver, BC, Canada, 3Biostatistics, Faculty of Health Sciences, Simon Fraser University / Arthritis Research Canada, Burnaby, BC, Canada, 4Arthritis Research Canada, Richmond, BC, Canada, 5University of British Columbia, Arthritis Research Canada, Richmond, BC, Canada, 6Arthritis Research Canada/ University of British Columbia, Vancouver, BC, Canada

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: death, Epidemiologic methods, population studies and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Epidemiology and Public Health I: Lung, Bone, and Infection Outcomes

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: In prior work, we found a higher incidence of hip fractures in RA than age and sex matched general population controls (4.1 vs. 2.9 per 1000 PY). To assess burden of disease, we compared age- and sex-adjusted all-cause mortality post hip fracture in RA and general population controls.

Methods: We conducted a retrospective study of a population-based incident RA cohort, using administrative health data. Using physician billing data, we identified all people with RA onset between 1997 and 2009 in a Canadian province. Controls (with no diagnosis of RA or other inflammatory arthritis) were randomly selected from the general population, matched 2:1 to RA cases on birth yr, gender and index yr. RA patients and controls with prior hip fractures, pathological fractures or Paget’s disease were excluded. Hip fractures were identified using hospitalization data (ICD9-CM codes 820.0, 820.2; ICD10-CA codes S72.0, S72.1, S72.2), from ≤25 codes defining reason for admission or complications during hospitalization. RA individuals and controls were followed from incident hip fracture to death, last health care use, or study end (Dec. 2014). Mortality data was obtained from Vital Statistics. Cox-proportional hazard models, adjusted for age and sex, compared mortality risk in RA vs. controls with a hip fracture.

Results: The cohort included 60,101 incident RA cases and 120,462 controls, of whom 2463 (4.1%) RA individuals and 3566 (3.0%) controls sustained an incident hip fracture and make up the study sample (78% females in RA and 81%s in controls; mean (SD) age at time of fracture: 78.9(10.9) yrs for RA and 82.1(9.0) yrs for controls). Crude all-cause mortality rate post hip fracture was 5.9% (n=143) and 8.2% (n=288) at 30 days; and 19.9% (n=481) and 24.5% (n=854) at 1-yr, for RA and controls, respectively. After age and sex adjustment, RA persons with hip fractures had a 17.5% lower risk of death than persons without RA at 30-days and 10.2% lower risk at 1-yr. The mean age at death for 30-day mortality was 83.9 yrs for RA and 86.1 yrs for controls.

Conclusion: Despite a higher incidence of hip fractures in RA, the 30-day and 1-year post hip fracture all-cause mortality was lower in RA than controls, after adjusting for sex and age at time of fracture. Further research is needed to understand whether mortality differences are related to co-morbidities, differences in post-op care, or other characteristics influencing post-fracture mortality risk.

 


Disclosure: C. A. Jones, None; P. Guy, None; H. Xie, None; E. C. Sayre, None; D. Lacaille, None.

To cite this abstract in AMA style:

Jones CA, Guy P, Xie H, Sayre EC, Lacaille D. Mortality Post Hip Fracture in Rheumatoid Arthritis Compared to General Population Controls, a Population-Based Study [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/mortality-post-hip-fracture-in-rheumatoid-arthritis-compared-to-general-population-controls-a-population-based-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mortality-post-hip-fracture-in-rheumatoid-arthritis-compared-to-general-population-controls-a-population-based-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology